Summary:
If you have relapsing-remitting multiple sclerosis (RRMS) and are between the ages of 18-65, you may
want to join this study evaluating a new investigational drug that may help reduce your relapses.
Participation is voluntary.
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Have RRMS and 1 documented
relapse during the previous
year or 2 documented relapses
during the previous 2 years
Qualified Participants May Receive:
Study-related medical
evaluations and study drug at no cost. Compensation
for time and reasonable reimbursement for travel related expenses are available. Participation is voluntary.